In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsor

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by AstraZeneca.

AstraZeneca
Abstract Slides/e-posters Video Report ESC TV Interview
 
RAAS inhibition in heart failure: are we hitting the target?
Presenter: S D Anker (Gottingen,DE)
2016
more
 
Summary and close - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.
Presenter: C W Hamm (Bad Nauheim,DE)
2016
more
 
The patient journey after an acute coronary syndrome - A clinical case study.
Presenter: S James (Uppsala,SE)
2016
more
 
Welcome and introduction - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.
Presenter: D Capodanno (Catania,IT)
2016
more
 
Who, when and why - The rationale to treat beyond 12 months.
Presenter: M Bonaca (Boston,US)
2016
more
 
Differentiating anti-platelet therapies: pharmacological evidence. Discussion.
Presenter: R F Storey (Sheffield,GB)
2015
more
 
Discussion - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.
Presenter: K A A Fox (Nethy Bridge,GB), C W Hamm (Bad Nauheim,DE), M Sabatine (Boston,US), N Danchin (Paris,FR)
2015
more
 
Dual anti-platelet therapy after acute coronary syndromes – should we continue beyond 12 months? Contra.
Presenter: N Danchin (Paris,FR)
2015
more
 
Dual anti-platelet therapy after acute coronary syndromes – should we continue beyond 12 months? Pro.
Presenter: M Sabatine (Boston,US)
2015
more
 
Introduction - Targeting the high-risk patient: evolving concepts on optimally modifying risk by lipid-modulating therapies.
Presenter: C M Ballantyne (Houston,US)
2015
more

ESC Congress 365 only features resources for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

AstraZeneca